Encompass Health (NYSE: EHC) director granted 87 RSUs from dividend credit

Rhea-AI Filing Summary

Encompass Health Corp director reports dividend-linked RSU award

Encompass Health Corp director Leslye G. Katz filed a Form 4 reporting an automatic award of 87 restricted stock units (RSUs) of Encompass Health common stock on January 15, 2026. The RSUs were credited at a price of $0 per unit, increasing her directly held beneficial ownership to 47,839 shares.

According to the footnote, non-employee directors receive additional RSUs in connection with common stock dividend payments. On January 15, 2026, Encompass Health paid a cash dividend of $0.19 per share, and the RSU credit was calculated using the closing stock price of $102.80 on the dividend payment date.

Insider Trade Summary

Net Buyer: 87 shares

Net Buy 1 txn

Insider KATZ LESLYE G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	87	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 47,839 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/16/2026 - 04:24 PM Learn about SEC filing dates

FAQ

What did Encompass Health (EHC) report in this Form 4 filing?

The filing reports that director Leslye G. Katz received an automatic award of 87 restricted stock units (RSUs) of Encompass Health common stock on January 15, 2026, tied to a dividend payment.

How many Encompass Health shares does Leslye G. Katz own after this transaction?

After the reported RSU award, Leslye G. Katz beneficially owns 47,839 shares of Encompass Health common stock in direct form.

What was the price and type of transaction reported for Encompass Health (EHC)?

The transaction is coded as an acquisition and reflects an award of 87 RSUs at a price of $0 per unit, rather than an open-market purchase or sale.

Why did Leslye G. Katz receive 87 RSUs from Encompass Health?

The footnote explains that, under outstanding restricted stock unit award agreements, non-employee directors receive additional RSUs in connection with common stock dividend payments. The 87 RSUs reported are associated with such a dividend.

What dividend did Encompass Health pay that led to this RSU credit?

On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share, which was used to calculate the number of RSUs credited.

How were the 87 RSUs for the Encompass Health director calculated?

The number of RSUs credited equals the product of the RSUs already in the director's account on the dividend record date and the $0.19 per-share dividend, divided by the $102.80 closing price on the dividend payment date.

Is this Encompass Health Form 4 transaction a direct or indirect holding?

The filing shows the holdings as Direct (D) ownership by Leslye G. Katz, with no separate entity or indirect ownership structure noted.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KATZ LESLYE G

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	01/15/2026		A		87(1)	A	$0	47,839	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Leslye G. Katz	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.